Show simple item record

2012 02 March Thomas Caskey interview

dc.contributor Maxson, Kathryn
dc.contributor Cook-Deegan, Robert
dc.date.accessioned 2013-07-16T23:33:49Z
dc.date.available 2014-07-01T04:30:04Z
dc.date.issued 2013-07-16
dc.identifier.uri https://hdl.handle.net/10161/7696
dc.description Thomas Caskey, telephone interview by Kathryn Maxson and Robert Cook-Deegan, conducted from Durham, NC, 2 March 2012. Caskey directed the genome center at Baylor College of Medicine—a recipient of some of the first NIH HGP mapping and early sequencing grants—until 1994. (In 1996 this center became the Baylor Human Genome Sequencing Center, ultimately one of the five most productive sequencing centers of the HGP.) After leaving Baylor, Caskey became Senior Vice President, Human Genetics and Vaccines Discovery, at Merck Research Laboratories, where he oversaw funding for the Merck Gene Index Project. This initiative, a partnership with Washington University in St. Louis, used Merck funds to place EST sequences in the public domain for research and development. This transcript is available beginning 1 July 2014. Keywords: Human Genome Project, HGP, interview, Bermuda Principles, Bermuda Accord, International Strategy Meetings on Human Genome Sequencing, data sharing, science policy, genomics, genome, genome sequence, genetics, DNA sequence, DNA, deoxyribonucleic acid, NIH, National Institutes of Health, DOE, Department of Energy, Baylor College of Medicine, Baylor Human Genome Sequencing Center, G-5, Merck, Merck Research Laboratories, Merck Gene Index Project, EST sequencing, Thomas Caskey.
dc.description.sponsorship This research was supported by the NHGRI-funded Duke Center for Public Genomics, P50 HG 003391, with supplementary funding from the Ewing Marion Kauffman Foundation.
dc.language.iso en_US
dc.title 2012 02 March Thomas Caskey interview
dc.type Interview


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record